June 12, 2026

In the coming weeks, the Medical Innovation Olympics will bring together healthcare innovators across biotech, medtech, AI, and life sciences to showcase breakthrough concepts and products. Participants will have the opportunity to refine their presentations and benefit from Amedea Pharma’s marketing, press releases, publications, and deep networking with industry experts and peers.

See the below TRACKS in 2026 across two Event Categories: CONCEPTS or PRODUCTS that must have initiated or significantly changed since October 21, 2025 will be eligible from startup founders, scientists, students, volunteers, patients, non-profit organizations, and healthcare professionals:
Olympic Trials Session 1: June 12 (5-minute presentations – CONCEPTS or PRODUCTS, Submissions open June 1)
Olympic Trials Session 2: September 18 (5-minute presentation – CONCEPTS or PRODUCTS, Submissions open September 7)
Main Event – October 1-16: Expert Panels, Keynotes from Global Guest Speakers, Leaders, Startups, Debates, Workshops, On-Demand Networking, and Multiple rounds of Competition via 10-minute live presentations + Live Scoring/Feedback from Investors, Industry Expert Judges
Judges will begin reviewing submissions on June 1, and on June 12 the first Olympic Trials session will feature 5-minute live presentations, Q&A, and live voting, with top-scoring teams qualifying for the October 1–16 main event.

September 24, 2026

1:30 PM EDT

Shaping treatments and improving patient lives means constantly learning and adapting. With Tufts University’s online life sciences micro-credentials, you’ll build in-demand skills and earn credentials that reflect your growing expertise.
Areas of focus include:
● Communicating scientific information clearly and effectively
● Leading & managing complex projects
● Navigating emerging technologies & workplace change
● Applying agile methods to projects & teams
● Leading change across organizations
Whether you’re advancing in your current role or preparing for what’s next, discover learning opportunities that can help you maximize the impact of your work.
Courses are facilitated by Tufts experts and practitioners and are completely self-paced, allowing you the flexibility to grow your skills on a schedule that works for you.

October 7, 2026

12:00 PM EDT

Join Nucleate and ARPA-H for a one-hour session on the agency’s Emerging Health Innovators initiative, a funding opportunity built to support early-career researchers chasing ambitious, high-impact ideas. EHI program manager Sam Gussman-Toh will walk through what ARPA-H actually funds, how the initiative works, key dates and resources, and what goes into a competitive submission. Free and open to researchers across biomedical science, health, engineering, and data science.

October 7, 2026

12:00 PM EDT

BioAngels’ founder Yaniv Sneor will be hosting his “Demystifying Life Science Angel Investing” webinar. Designed for investors and life science professionals seeking to leverage their expertise, this session will offer insights into the realities of early-stage investing in biotechnology and life sciences.

October 8, 2026

12:00 PM EDT

Join Weill Cornell Medicine’s BioVenture eLab and the Tri-I Startup Venture Group to learn how AI is enhancing healthcare at Weill Cornell, with a discussion of the new AI-powered devices being built by researchers there. The event is part of AI Week NY by Pulse NYC, a community-led festival celebrating innovation across the AI ecosystem.

October 8, 2026

8:00 AM EDT

The Alan W. Rothschild Innovation Award honors the life and legacy of Alan Rothschild, whose creativity, vision, and entrepreneurial spirit continue to inspire innovators across our region. The award was established to support the development and advancement of emerging science and transformative technologies. Presented annually, it provides financial support to a pitch competition winner who demonstrates exceptional innovation and commercial potential. This year, the event will begin with Innovation Across Upstate Medical University, a showcase highlighting innovations from researchers, entrepreneurs, industry partners, investors, and friends of Upstate Medical University.

Celebrating 10 Years of Innovation
Since completing construction in 2016, the Central New York Biotech Accelerator (CNYBAC) has supported numerous startup companies developing innovative medical devices, pharmaceuticals, biologics, and health technologies. Collectively, CNYBAC client companies have generated more than $40M in annual economic impact through grants and investments, engaged regional and statewide service providers, and created opportunities for Upstate Medical University graduates. Most importantly, these companies are bringing forward new diagnostics, treatments, and healthcare solutions that improve patient outcomes and support caregivers. We hope you will join us for this exciting day of entrepreneurship, innovation, and celebration!

October 8, 2026

8:00 AM EDT

Join Greater Rochester Chamber and partners from across the NY SMART I-Corridor for this special Rochester TRENDS event on Thursday, October 8 from 8 AM to Noon at Paychex Auditorium at the Strong Museum of Play to hear the latest industry updates, explore emerging opportunities, and connect directly with the organizations that can help your business compete and succeed in this rapidly expanding market.
The NY SMART I-Corridor Tech Hub brings together partners across Buffalo, Rochester, Syracuse, and Ithaca to help businesses understand where they fit, connect with customers and partners, and access funding, technical assistance, workforce solutions, commercialization support, and other tools to accelerate growth.

October 13, 2026

5:30 PM EDT

Join us for a panel and networking event co-hosted by NewYorkBIO and Proskauer

Deal-Ready IP: How Patent Diligence Shapes Successful Licensing, M&A, and Financings
Discussion would cover portfolio strategy and dealmaking, with discussion that would engage established companies actively doing deals and investors evaluating opportunities, as well as earlier-stage businesses or AMCs that will seek to out-license or sell their IP. Potential topics include how investors evaluate IP strength, FTO analysis, PTAB/post-grant trends, inventorship and ownership recordkeeping for AI-assisted R&D, and structuring license & collaboration deals.

Attendance is limited to NewYorkBIO members and invited guests. Service provider attendance is limited.

October 13, 2026

8:30 AM EDT

Join the Australian Securities Exchange (ASX), Bell Potter Securities, Johnson Winter Slattery (JWS) and Grant Thornton for a private breakfast exploring the Australian public markets as a potential listing, growth capital and liquidity pathway for healthcare and life sciences companies.

Designed for founders, private equity and venture capital investors and their portfolio companies, the session will provide a practical introduction to the ASX market, including the opportunity to access Australia’s US$3.2 trillion pension market, and the considerations for US healthcare and life sciences companies evaluating an Australian listing. Attendance is complimentary, but places are limited.